Open Access
CC BY-NC-ND 4.0 · Eur J Dent 2021; 15(04): 768-775
DOI: 10.1055/s-0041-1729139
Review Article

Periodontal Diseases and COVID-19: A Scoping Review

Authors

  • Lisa Basso*

    1   Laboratoire des Multimatériaux et Interfaces, Claude Bernard University Lyon 1, Villeurbanne, France
  • Doriane Chacun*

    1   Laboratoire des Multimatériaux et Interfaces, Claude Bernard University Lyon 1, Villeurbanne, France
    2   Faculty of Odontology, Claude Bernard University Lyon 1, Lyon, France
    3   Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Unité Fonctionnelle de Parodontologie, Lyon, France
  • Kadiatou Sy

    2   Faculty of Odontology, Claude Bernard University Lyon 1, Lyon, France
    3   Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Unité Fonctionnelle de Parodontologie, Lyon, France
    4   INSERM, Controlled Drug Delivery Systems and Biomaterials, University of Lille, France
  • Brigitte Grosgogeat

    1   Laboratoire des Multimatériaux et Interfaces, Claude Bernard University Lyon 1, Villeurbanne, France
    2   Faculty of Odontology, Claude Bernard University Lyon 1, Lyon, France
    5   Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Clinical Research Unit, Lyon, Lyon France
  • Kerstin Gritsch

    1   Laboratoire des Multimatériaux et Interfaces, Claude Bernard University Lyon 1, Villeurbanne, France
    2   Faculty of Odontology, Claude Bernard University Lyon 1, Lyon, France
    3   Hospices Civils de Lyon, Service de Consultations et de Traitements Dentaires, Unité Fonctionnelle de Parodontologie, Lyon, France
Preview

Abstract

The aim of this scoping review was to present the existing literature regarding the relationship between periodontal diseases and coronavirus disease 2019 (COVID-19). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping review guidelines was followed. Articles were retrieved from PubMed/MEDLINE and Scopus databases and screened to include studies relating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 to periodontal cells and/or tissues and/or diseases. Twenty-five papers were included; consisting of six reviews, seven original articles, six short reports, four letters to the editor, one commentary, and one case report. The articles were allocated to three different topics: (i) hypotheses on the relationship between periodontal diseases and COVID-19; (ii) risk factors and comorbidities common to periodontitis and COVID-19; (iii) periodontal manifestations of COVID-19. Certain molecules (angiotensin-converting enzyme-2, furin, cathepsin, TMPRSS2...) that are found at a high level in periodontal tissues, particularly in patients with periodontitis, are involved in the mechanism of entry of SARS-CoV-2 into cells. Periodontopathic bacteria could also play a direct role in the mechanism of entry of SARS-CoV-2 by cleaving the S-protein, and the cytokines produced during periodontitis could add to the cytokine storm found in the severe forms of COVID-19. It thus appears that the treatment of periodontitis, which allows a reduction in periodontopathic bacteria and of the local and systemic inflammation state, could be part of a strategy to prevent the development of severe forms of COVID-19.

* *These are the co-first authors for this article.




Publikationsverlauf

Artikel online veröffentlicht:
09. September 2021

© 2021. European Journal of Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India